Johan Bussink Selected Research

Johan Bussink Research Topics

Disease

100	Neoplasms (Cancer) 05/2024 - 09/2002
75	Hypoxia (Hypoxemia) 05/2024 - 12/2002
37	Squamous Cell Carcinoma of Head and Neck 01/2022 - 09/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020 - 07/2007
20	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022 - 12/2002
14	Carcinoma (Carcinomatosis) 11/2017 - 12/2002
13	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2007
12	Breast Neoplasms (Breast Cancer) 02/2020 - 08/2011
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 04/2003
7	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2006
5	Necrosis 01/2022 - 07/2006
4	Adenocarcinoma 12/2019 - 06/2012
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 02/2005
3	Laryngeal Neoplasms (Laryngeal Cancer) 03/2014 - 10/2013
2	Atherosclerosis 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Starvation 01/2018 - 08/2011
2	Triple Negative Breast Neoplasms 01/2015 - 10/2011
2	Sarcoma (Soft Tissue Sarcoma) 08/2012 - 06/2012
1	Melanoma (Melanoma, Malignant) 05/2024
1	Colonic Neoplasms (Colon Cancer) 05/2024
1	Thyroid Nodule (Nodule, Thyroid) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

29	pimonidazoleIBA 01/2023 - 09/2002
25	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2008
18	Carbonic Anhydrase IXIBA 01/2023 - 12/2002
16	ErbB Receptors (EGF Receptor)IBA 01/2016 - 06/2009
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2008
12	Messenger RNA (mRNA)IBA 01/2022 - 08/2011
11	carbogenIBA 01/2022 - 12/2002
10	Oxygen (Dioxygen)IBA 05/2024 - 09/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2007
10	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 06/2002
10	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 06/2008
9	Cetuximab (Erbitux)FDA Link 01/2016 - 08/2011
9	Phosphotransferases (Kinase)IBA 06/2015 - 06/2009
6	Pentetic Acid (DTPA)FDA LinkGeneric 10/2022 - 08/2011
5	Tamoxifen FDA LinkGeneric 05/2024 - 02/2014
5	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 05/2012 - 09/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Radioisotopes (Radionuclides)IBA 01/2022 - 07/2010
4	MK 2206IBA 01/2020 - 10/2012
4	alovudineIBA 04/2013 - 05/2007
4	fluoroazomycin arabinosideIBA 09/2009 - 03/2008
4	CCI 103FIBA 02/2007 - 09/2004
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2010
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 12/2018
3	Hypoxia-Inducible Factor 1IBA 01/2022 - 08/2011
3	G250 monoclonal antibodyIBA 07/2021 - 01/2019
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2019 - 02/2014
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2019 - 06/2012
3	beta-Aminoethyl Isothiourea (AET)IBA 11/2018 - 10/2015
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2014 - 03/2008
3	Crystallins (Crystallin)IBA 04/2014 - 03/2013
3	ParaffinIBA 09/2013 - 05/2010
3	Small Interfering RNA (siRNA)IBA 09/2013 - 08/2011
2	Atovaquone (Mepron)FDA Link 05/2024 - 07/2021
2	ElementsIBA 05/2024 - 03/2008
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023 - 02/2006
2	RadiopharmaceuticalsIBA 01/2022 - 07/2010
2	AntibodiesIBA 01/2022 - 01/2019
2	CytokinesIBA 01/2022 - 01/2020
2	InterferonsIBA 01/2021 - 01/2018
2	Estrogen ReceptorsIBA 02/2020 - 10/2011
2	mouse dectin-2IBA 01/2020 - 01/2019
2	C-Type Lectins (C-Type Lectin)IBA 01/2020 - 01/2019
2	GlutaminaseIBA 12/2019 - 12/2018
2	Contrast MediaIBA 01/2018 - 11/2017
2	Chloroquine (Aralen)FDA LinkGeneric 01/2018 - 09/2013
2	Monoclonal AntibodiesIBA 08/2015 - 07/2010
2	Lysosomal Membrane ProteinsIBA 06/2015 - 09/2013
2	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 11/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 03/2013
2	Growth Factor ReceptorsIBA 11/2013 - 03/2013
2	VimentinIBA 10/2013 - 06/2011
2	Cadherins (E-Cadherin)IBA 10/2013 - 06/2011
2	Epidermal Growth Factor (EGF)IBA 09/2013 - 01/2007
2	Activating Transcription Factor 4IBA 09/2013 - 01/2013
2	Indicators and Reagents (Reagents)IBA 06/2013 - 04/2013
2	Adenosine Triphosphate (ATP)IBA 06/2012 - 06/2008
2	NitroimidazolesIBA 07/2010 - 12/2002
2	Idoxuridine (Stoxil)FDA LinkGeneric 05/2010 - 05/2007
2	fluoromisonidazoleIBA 10/2008 - 08/2006
1	Metformin (Glucophage)FDA LinkGeneric 05/2024
1	triphenylphosphoniumIBA 05/2024
1	Green Fluorescent ProteinsIBA 05/2024
1	IACS-010759IBA 05/2024
1	AcidsIBA 01/2023
1	EnzymesIBA 01/2023
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2023
1	Bromodeoxyuridine (BrdU)IBA 01/2022

Therapy/Procedure

74	Radiotherapy 05/2024 - 06/2002
45	Therapeutics 10/2022 - 12/2002
11	Drug Therapy (Chemotherapy) 01/2019 - 09/2004
10	Aftercare (After-Treatment) 01/2018 - 09/2004
5	Immunotherapy 05/2024 - 11/2019
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2019 - 12/2016
4	Chemoradiotherapy 11/2018 - 04/2013